How OCM™ Works

OCM™ is designed to do far more than act as a simple barrier. As an amorphous solid, this matrix conforms completely to the wound bed, flowing directly into tunnels and crevices to ensure maximum surface contact and deliver vital building blocks for tissue regeneration.

Product Highlights

Clinical Benefits of OCM™

biofilm-icon

Reduces Biofilm Impact

inflammation-icon

Decreases Inflammation

proliferation-icon

Increases Proliferation

remodelling-icon

Supports Remodeling

Clinical Distribution

Clinical Supply & Packaging

OCM™ is optimized for real-world clinical workflow utility, designed for simple and fast administration at the patient bedside. Formulated and manufactured in the USA.

single-use-icon
HCPCS A2014

Single-use Packaging

OCM™ is supplied sterile for single-use application. Administered by healthcare providers using aseptic techniques, each device covers approximately a 16 cm² area. Discard all opened and unused portions.

procurement-icon
Ordering & Supply

Procurement Channels

To order OCM™, contact customerservice@omeza.com or call 877-431-4753. OCM™ is available through Marathon Medical, a prime vendor on the Veterans Affairs Federal Supply Schedule Service (Contract Number: 36F79718D0321).

Mechanism of Action

Detailed Step-by-Step Process

Matrix Conformance

The anhydrous matrix conforms to both regular and irregular wound beds, establishing an immediate protective barrier over the exposed tissue.

02

OCM™ provides immediate structural coverage

Nutrient Infusion

A specialized blend of essential omega fatty acids, peptides, and plant-derived oils and waxes supplies vital nutrients directly to the wound bed to restart the natural healing cascade.

03

OCM™ is a malleable solid to fit any wound shape

Structural Regeneration

A three-dimensional scaffolding framework allows the patient’s own healthy cells to migrate and multiply, actively facilitating robust tissue regeneration and remodeling.

image

Formulated under strict cleanroom conditions

Advanced Healing

The factors stalling the wound are overcome, successfully pushing the chronic wound out into progressive phases of healing and closure.

04

Formulated under strict cleanroom conditions

02

OCM™ provides immediate structural coverage

03

OCM™ is a malleable solid to fit any wound shape

image

Formulated under strict cleanroom conditions

04

Formulated under strict cleanroom conditions

ocm-box-render
Data Review

Clinical Evidence Shows
60% PAR* In 4 Weeks

*Percentage Area Reduction

Case Studies

Observational Progression Overview

after-treatment

Before Omeza Treatment

Diabetic foot ulcer associated with Charcot foot. Once-weekly Omeza treatment commenced on 27 January 2022.

before-treatment

After Omeza Treatment

Ulcer healed on 31 March 2022.

Request a Conversation with a Rep

Contact us today to request a representative and introduce OCM™ to your
wound care protocols.

Contact Us
COMPLETE WOUND CARE, DELIVERED SIMPLY. COMPLETE WOUND CARE, DELIVERED SIMPLY. COMPLETE WOUND CARE, DELIVERED SIMPLY. COMPLETE WOUND CARE, DELIVERED SIMPLY.